These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2741111)
1. [Use of calcium antagonists in therapy of bronchial asthma]. Alekseev VG; Sinopal'nikov AI; Efimov AV Ter Arkh; 1989; 61(3):27-31. PubMed ID: 2741111 [TBL] [Abstract][Full Text] [Related]
2. [The possibilities and prospects in using the calcium antagonist korinfar in patients with bronchial asthma]. Sinopal'nikov AI; Efimov AV; Alekseev VG Ter Arkh; 1988; 60(3):78-81. PubMed ID: 3388279 [TBL] [Abstract][Full Text] [Related]
3. [The clinico-functional effectiveness of calcium antagonists in correcting the bronchial hyperreactivity of bronchial asthma patients]. Fedoseev GB; Sinitsina TM; Shchemelinina TI Ter Arkh; 1990; 62(1):63-6. PubMed ID: 2333621 [TBL] [Abstract][Full Text] [Related]
5. Effect of aerosolised verapamil and nifedipine in bronchial asthma. Gupta S; Meena HS; Chopra R; Bidani R J Assoc Physicians India; 1993 Jul; 41(7):425-7. PubMed ID: 8300487 [TBL] [Abstract][Full Text] [Related]
6. [Study of the effects of calcium antagonists on respiration mechanics in patients with occlusive ventilation impairment]. Frank-Piskorska A; Wasek Z; Malinowski R Wiad Lek; 1989 Mar; 42(5):278-83. PubMed ID: 2815744 [TBL] [Abstract][Full Text] [Related]
7. Effect of calcium channel antagonists on cholinergic bronchial responsiveness in asthma. Talwar D; Jindal SK J Assoc Physicians India; 1993 May; 41(5):279-80. PubMed ID: 8300460 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the protective effects of nifedipine and verapamil in patients with bronchial hyperreactivity]. Malinowski R; Wasek Z; Frank-Piskorska A Wiad Lek; 1989 Feb; 42(3):129-33. PubMed ID: 2696203 [TBL] [Abstract][Full Text] [Related]
10. [Calcium channel blockers and their value in the treatment of bronchial asthma]. Wasek Z Pneumonol Pol; 1988 Oct; 56(10):467-71. PubMed ID: 3254510 [No Abstract] [Full Text] [Related]
11. Use of inhaled calcium channel blocking agents in the treatment of asthma. Davies RJ; Bennett J; Osman J J Asthma; 1984; 21(6):443-50. PubMed ID: 6441795 [TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion]. LitvitskiÄ PF Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755 [TBL] [Abstract][Full Text] [Related]
17. What is preferable in unstable angina, beta-blockade or calcium-inhibition? Hugenholtz PG; Serruys PW; Simoons ML Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():199-209. PubMed ID: 6134510 [TBL] [Abstract][Full Text] [Related]
18. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy]. Korovina EP Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289 [TBL] [Abstract][Full Text] [Related]
19. Calcium channel blocking drugs in the management of drug dependence, withdrawal and craving. A clinical pilot study with nifedipine and verapamil. Shulman A; Jagoda J; Laycock G; Kelly H Aust Fam Physician; 1998 Jan; 27 Suppl 1():S19-24. PubMed ID: 9503731 [TBL] [Abstract][Full Text] [Related]
20. Slow channel inhibitors verapamil and nifedipine in the management of hypertension. Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]